AndreaBozzo/ceres-open-data-index huggingface dataset:
Voluntary self-poisoning as a cause of admission to a tertiary hospital internal medicine clinic in Piraeus, Greece within a year

Background
          Out of 1705 patients hospitalised for various reasons in the 3rd Internal Medicine Department of the Regional General Hospital of Nikaea, in Piraeus, 146(8,5%) persons were admitted for drug intoxication between November 1999 and November 2000.
        
        
          Methods
          On average, these persons [male 50(34,2%) – female 96(65,8%)] were admitted to the hospital within 3.7 hours after taking the drug.
        
        
          Results
          The drugs that were more frequently taken, alone or in combination with other drugs, were sedatives (67.1%), aspirins and analgesics (mainly paracetamol) (43.5%). 38.3% of patients had a mental illness history, 31.5% were in need of psychiatric help and 45.2% had made a previous suicide attempt. No death occurred during the above period and the outcome of the patients' health was normal. After mental state examination, the mental illnesses diagnosed were depression (20.96%), psychosis (15.32%), dysthymic disorder (16,2%), anxiety disorder (22.58%) and personality disorder (8.87%).
        
        
          Conclusions
          Self-poisoning remains a crucial problem. The use of paracetamol and sedatives are particularly important in the population studied. Interpersonal psychiatric therapy may be a valuable treatment after people tried to poison themselves.
Compound 525642: N,N-Dimethyl-N'-pentyl-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-pentylbenzenecarboximidamide. Molecular Formula: C14H22N2. Molecular Weight: 218.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Indicators of Health Insurance Coverage at the Time of Interview

The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of Covid-19 on American households.  The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness.

The survey was designed to meet the goal of accurate and timely weekly estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, sex, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions.
Patent AT-E400042-T1: [Translated] CONTROL SYSTEM FOR A BANKNOTE HANDLING DEVICE

The present invention relates to a device for handling banknotes, comprising a transporting system (1), an infeeding and outfeeding unit (2), an identifying unit (3) as well as a first, second and so on to a last storage unit (41, 42, . . . , 4n), each one adapted to the storage of banknotes. The device is adapted to an infeed of a banknote through the infeeding and outfeeding unit (2), a transportation of the banknote by means of the transporting system (1) past the identifying unit (3), an identification of the banknote, a transportation of the banknote to a storage unit intended for the banknote according to the identification, as well as an infeed of the banknote to the intended storage unit. Particularly, it is taught that the device comprises a central control unit (5), adapted to communicate with a first local control unit (51) arranged at the first storage unit (41,) a second local control unit (52) arranged at the second storage unit (42) and so on to a last local control unit (5n) arranged at the last storage unit (4n). The central unit (5) is further adapted to communicate with a position sensor (6) as well as the identifying unit (3). The respective control unit (5, 51, 52, . . . , 5n) has a common synchronous apprehension of the position of the transporting system 1, and when the identifying unit (3) has identified a banknote, and when the position sensor (6) has indicated the position of the banknote in the transporting system (1), the central control unit (5) communicates the position of the banknote to the intended local control, unit (52), which directs the storage unit (42) associated therewith to an infeed, being independent of other units, of the banknote to the storage unit (42) when the position in the transporting system (1) reaches the intended storage unit (42).
How well do second-year students learn physical diagnosis? Observational study of an objective structured clinical examination (OSCE)

Background
          Little is known about using the Objective Structured Clinical Examination (OSCE) in physical diagnosis courses. The purpose of this study was to describe student performance on an OSCE in a physical diagnosis course.
        
        
          Methods
          Cross-sectional study at Harvard Medical School, 1997–1999, for 489 second-year students.
        
        
          Results
          Average total OSCE score was 57% (range 39–75%). Among clinical skills, students scored highest on patient interaction (72%), followed by examination technique (65%), abnormality identification (62%), history-taking (60%), patient presentation (60%), physical examination knowledge (47%), and differential diagnosis (40%) (p < .0001). Among 16 OSCE stations, scores ranged from 70% for arthritis to 29% for calf pain (p < .0001). Teaching sites accounted for larger adjusted differences in station scores, up to 28%, than in skill scores (9%) (p < .0001).
        
        
          Conclusions
          Students scored higher on interpersonal and technical skills than on interpretive or integrative skills. Station scores identified specific content that needs improved teaching.
2014 CMHS Uniform Reporting System (URS) Table for Northern Mariana Islands

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Northern Mariana Islands. The URS territories reporting system is collected annually to support the Community Mental Health Services Block Grant program. Territories Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E400477-T1: [Translated] METHOD FOR PRODUCING AN AIR BAG AND AIRBAG

A method of making an air-bag is disclosed in which a selected plastics material is blow moulded within an appropriate mould to form a blow moulded air-bag. The mould is such that the blow moulded air-bag ( 1 ) has at least one indented region, such as a central oval region ( 10 ) of the upper part ( 7 ) of the air-bag, which, on inflation of the air-bag, becomes outwardly extending.
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice

Background
          The presynaptic protein α-synuclein is involved in a range of neurodegenerative diseases. Here we analyze potential compensatory mechanisms in α-synuclein null mutant mice. Furthermore, the findings reveal problems that may be associated with inbred mouse strains.
        
        
          Results
          Expression profiling by cDNA array technology in a transgenic mouse model revealed striking differences only in the expression level of α-synuclein. This was caused by a chromosomal deletion of the α-synuclein locus in the C57BL/6J inbred strain used for backcrossing. However, the deletion is only present in a subpopulation of C57BL/6J mice, namely animals from Harlan. No other genes are known to be affected by the deletion, which is estimated to be smaller than 2 cM. We propose to name this strain C57BL/6S. C57BL/6S animals appear phenotypically normal. They show no upregulation of β-synuclein or γ-synuclein, excluding a compensatory mechanism. Also, the expression of synphilin-1 was unaffected.
        
        
          Conclusions
          The C57BL/6S strain should help in the understanding of the physiological function of α-synuclein and its involvement in synucleinopathies. Also, the findings exemplify unexpected complications that may arise during the study of transgenic models or inbred strains, in particular when combined with genome wide screening techniques.
New York State Statewide Hospital Staff COVID-19 Vaccinations

<b>Note: This dataset is no longer updated as of 7/28/2023.</b>

This dataset includes information at the report date level by individual facilities on the total number of staff, how many staff are partially vaccinated, and how many are fully vaccinated. This information is only collected once a week from hospitals. The title of this dataset was initially the Hospital Electronic Response Data System (HERDS) Hospital Survey: Hospital Staff COVID-19 Vaccinations. The dataset was changed to its current title on 11/4/2021.
Network PUF - PY2019

The Network PUF (Ntwrk-PUF) is one of the seven files that make up the Marketplace PUF. The Ntwrk-PUF contains issuer-level data identifying provider network URLs. These data either originate from the Network ID template (i.e., template field), an Excel based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated)
Weekly Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Jurisdiction

• Weekly COVID-19 vaccination coverage estimates among children 6 months to 17 years is assessed through the National Immunization Survey (https://www.cdc.gov/vaccines/imz-managers/nis/about.html). 

• Weekly estimates of COVID-19 vaccination coverage among children through December 31, 2023, were calculated using data from the National Immunization Survey-Child COVID Module (NIS-CCM) (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-ccm). Beginning January 2, 2024, the NIS-CCM was discontinued, and questions regarding receipt of COVID-19 vaccination among children were added to the NIS-Flu (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-cim). 

• Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19.
Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific

Background
          Previous studies have revealed that tumour necrosis factor (TNF)-α is upregulated in fibrosing alveolitis (FA) in humans. The aim of this study was to compare the TNF-α secretory profile of alveolar macrophages (AMs) and peripheral blood monocytes (Mos) of patients with cryptogenic FA and systemic sclerosis (SSc), a rheumatological disorder in which lung fibrosis can occur. In particular, we wished to assess whether TNF-α levels differ between SSc patients with FA (FASSc) and a nonfibrotic group.
        
        
          Methods
          The reverse haemolytic plaque assay was used to evaluate the secretion of cytokine at a single cell level while immunostaining allowed subtyping of AMs and Mos.
        
        
          Results
          This study demonstrated a difference in total TNF-α levels produced by AMs when the levels in subjects with FA (cryptogenic FA and FASSc) were compared to levels in either SSc patients without FA (P = 0.0002) or normal healthy controls (P < 0.001). In addition, AMs from patients with FASSc secreted more TNF-α than those of patients with no FA (P = 0.003). In contrast, there were no significant differences in Mo TNF-α secretion between the groups. A positive correlation was found between total TNF-α level and number of neutrophils obtained by bronchoalveolar lavage from patients with FA (r = 0.49, P < 0.04). Finally, it was demonstrated that there was significant heterogeneity of TNF-α secretion and that a numerically significant subset of mononuclear phagocytes, RFD7, was responsible for more than 80% of TNF-α production.
        
        
          Conclusion
          By demonstrating the primary cell source of TNF-α in FASSc, more accurately targeted, possibly localized, anti-TNF strategies might be employed with success in the future.
Compound 526322: 2,3,7,8-Tetrabromo-1,9-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2,3,7,8-tetrabromo-1,9-dichlorodibenzo-p-dioxin. Molecular Formula: C12H2Br4Cl2O2. Molecular Weight: 568.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E39996-T1: [Translated] AIR-COOLABLE FIREPLACE WALL.

The invention relates to an air-cooled combustion chamber wall for combustion furnaces. The combustion chamber wall comprises at least one masonry wall with a space in the middle for the passage of cooling air along the side of the wall away from the combustion chamber side. To create a simple, stable and effective structure, the invention proposes that the masonry be made of bricks, whose walls enclose at least one air duct.
Treatment Episode Data Set: Admissions (TEDS-A-1994)

<p>The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.<br />
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.<br />
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".<br />
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).<br />
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.<br />
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.</p>
Sample Size and Population Estimate Tables (Prevalence Estimates) - 3.1 to 3.8

These detailed tables show sample sizes and population estimates from the 2012 National Survey on Drug Use and Health (NSDUH) Mental Health Detailed Tables. Samples sizes and population estimates are provided age group, gender, race/ethnicity, education level, employment status, county type, poverty level, insurance status, overal health, and geographic area.
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States

- Archived data are here:  https://data.cdc.gov/resource/uxgd-cqqc

- CDC is exploring use of data obtained from IQVIA§ (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices.  
 
- These projected pharmacy estimates include flu vaccinations that were billed for (i.e. claims) or paid by cash. Medical office projected estimates are claims-based only. 
 
- The sampled pharmacies and physician medical offices and the captured volume of transactions represent approximately 92% and 82% of influenza vaccines administered nationally, respectively. 
 
- Vaccinations administered in other settings such as workplaces and community settings are not included in these data. 
 

*National estimates for pharmacies and medical offices include vaccinations administered in 50 states and DC. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week. Week ending dates for prior seasons are aligned with the current season’s week ending dates. 

§ 1) King, L. M., Bartoces, M., Fleming-Dutra, K. E., et. al, L. A. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016external icon. Clinical Infectious Diseases, 70(3), 370-377. 2) McLaughlin, J. M., Swerdlow, D. L., Khan, F., et. Al (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United Statesexternal icon. Human vaccines & immunotherapeutics, 15(4), 841-849.
Compound 526621: 1-Propyldecyl cyclopentanecarboxylate

Chemical compound data from PubChem database. IUPAC Name: 3-[(2-methylfuran-3-yl)disulfanyl]pentan-2-one. Molecular Formula: C10H14O2S2. Molecular Weight: 230.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection

Background
          Gaps in disease surveillance capacity, particularly for emerging infections and bioterrorist attack, highlight a need for efficient, real time identification of diseases.
        
        
          Methods
          We studied automated records from 1996 through 1999 of approximately 250,000 health plan members in greater Boston.
        
        
          Results
          We identified 152,435 lower respiratory infection illness visits, comprising 106,670 episodes during 1,143,208 person-years. Three diagnoses, cough (ICD9CM 786.2), pneumonia not otherwise specified (ICD9CM 486) and acute bronchitis (ICD9CM 466.0) accounted for 91% of these visits, with expected age and sex distributions. Variation of weekly occurrences corresponded closely to national pneumonia and influenza mortality data. There was substantial variation in geographic location of the cases.
        
        
          Conclusion
          This information complements existing surveillance programs by assessing the large majority of episodes of illness for which no etiologic agents are identified. Additional advantages include: a) sensitivity, uniformity and efficiency, since detection of events does not depend on clinicians' to actively report diagnoses, b) timeliness, the data are available within a day of the clinical event; and c) ease of integration into automated surveillance systems.
          These features facilitate early detection of conditions of public health importance, including regularly occurring events like seasonal respiratory illness, as well as unusual occurrences, such as a bioterrorist attack that first manifests as respiratory symptoms. These methods should also be applicable to other infectious and non-infectious conditions. Knowledge of disease patterns in real time may also help clinicians to manage patients, and assist health plan administrators in allocating resources efficiently.
Compound 529120: 4-Quinazolone, 3-ethyl-2-propyl

Chemical compound data from PubChem database. IUPAC Name: 3-ethyl-2-propylquinazolin-4-one. Molecular Formula: C13H16N2O. Molecular Weight: 216.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice

Anti-tumor-necrosis-factor-α (TNF-α) monoclonal antibody was used to treat Tg197 transgenic mice, which constitutively produce human TNF-α (hTNF-α) and develop a progressive polyarthritic disease. Treatment of both young (7- or 8-week-old) and aged (27- or 28-week-old) mice commenced when at least two limbs showed signs of moderate to severe arthritis. The therapeutic efficacy of anti-TNF-α antibody was assessed using various pathological indicators of disease progression. The clinical severity of arthritis in Tg197 mice was significantly reduced after anti-TNF-α treatment in comparison with saline-treated mice and in comparison with baseline assessments in both young and aged mice. The treatment with anti-TNF-α prevented loss of body weight. Inflammatory pathways as reflected by elevated circulating hTNF-α and local expression of various proinflammatory mediators were all diminished by anti-TNF-α treatment, confirming a critical role of hTNF-α in this model of progressive polyarthritis. More importantly, the amelioration of the disease was associated with reversal of existing structural damage, including synovitis and periosteal bone erosions evident on histology. Repair of cartilage was age dependent: reversal of cartilage degradation after anti-TNF-α treatment was observed in young mice but not in aged mice.